These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20368214)

  • 1. Arterial hypertension defeated? Attacked from another angle.
    Pongrac Barlovic D; Cooper ME
    Diab Vasc Dis Res; 2009 Oct; 6(4):221-2. PubMed ID: 20368214
    [No Abstract]   [Full Text] [Related]  

  • 2. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
    Gewirtz JR; Bisognano JD
    Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential Approaches are Much Needed for "Real World" Management of Hypertension in the Era of "Hypertension Paradox".
    Kario K
    Curr Hypertens Rev; 2018; 14(1):2-5. PubMed ID: 29943699
    [No Abstract]   [Full Text] [Related]  

  • 4. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
    McConaghy JR
    J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of vascular disease in hypertension with special reference to diabetes.
    Yudkin JS
    Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADVANCE trial of great importance in preventing cardiovascular deaths in type 2 diabetes.
    Cardiovasc J Afr; 2007; 18(5):343-4. PubMed ID: 17985038
    [No Abstract]   [Full Text] [Related]  

  • 8. Introductory remarks.
    Velasco M; Bermúdez V; Israili ZH; Hernández-Hernández R
    Am J Ther; 2010; 17(3):236. PubMed ID: 20479578
    [No Abstract]   [Full Text] [Related]  

  • 9. Are there new threshold and goals in the treatment of arterial hypertension?
    Segura J; Ruilope LM
    Eur J Clin Invest; 2012 Aug; 42(8):914-20. PubMed ID: 22404687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial and pulmonary hypertension: risk assessment and current pharmacological and interventional management.
    Lüscher TF
    Eur Heart J; 2018 Dec; 39(47):4127-4131. PubMed ID: 30551139
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure control and impact on cardiovascular events in patients with type 2 diabetes mellitus: A critical analysis of the literature.
    Vargas-Uricoechea H; Cáceres-Acosta MF
    Clin Investig Arterioscler; 2019; 31(1):31-47. PubMed ID: 30274771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
    Franjic B; Marwick TH
    J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased arterial stiffness is associated with reduced plasma levels of beta-carotene in treated hypertensive patients with type 2 diabetes mellitus.
    Chung HK; Kang B; Lee JH; Shim JY; Park S; Lee SH; Park YK; Park E; Chung N; Shin MJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):e9-e11. PubMed ID: 19505810
    [No Abstract]   [Full Text] [Related]  

  • 15. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIRCADIAN RHYTHM OF BLOOD PRESSURE RESTORATION AND NEPHROTIC PROTEINURIA ALLEVIATION IN A PATIENT WITH CHRONIC KIDNEY DISEASE AFTER RENAL SYMPATHETIC DENERVATION.
    Prkacin I; Corić-Martinović V; Bulum T; Cavrić G; Đermanović-Dobrota V; Vidjak V
    Acta Clin Croat; 2015 Dec; 54(4):547-50. PubMed ID: 27017734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hypertension in diabetic patients: outstanding issues.
    Camafort-Babkowski M; Barrios V; Coca A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):721-8. PubMed ID: 21714603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes.
    Owen AJ; Retegan C; Rockell M; Jennings G; Reid CM
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):643-7. PubMed ID: 19076166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight].
    Karpov RS; Koshel'skaia OA; Khoroshilova IV
    Ter Arkh; 2010; 82(9):23-30. PubMed ID: 21086616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes: targeting blood pressure below 140/80 mmHg.
    Prescrire Int; 2011 Mar; 20(114):77. PubMed ID: 21648231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.